Strides get USFDA nod for two tablets

July 03, 2018 12:00 am | Updated 05:10 am IST - Bengaluru

Strides gets USFDA approval for two drugs

Strides Shasun announced that its wholly-owned subsidiary Strides Pharma Global Pte. had received the final approval for anti-inflammatory, pain-relieving Ibuprofen tablets, 200 mg, from the USFDA. It also received a tentative approval for its Para IV filing of Milnacipran Hydrochloride tablets from the USFDA. These tablets, meant to treat fibromyalgia that affects tendons, ligaments and supporting tissues.

Top News Today


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.